Canton Hathaway, LLC Moderna, Inc. Transaction History

Canton Hathaway, LLC

$366 Million
Q2 2024

A detailed history of Canton Hathaway, LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Canton Hathaway, LLC holds 1,421 shares of MRNA stock, worth $77,643. This represents 0.05% of its overall portfolio holdings.

Number of Shares

1,421

Previous 601 136.44%

Holding current value

$77,643

Previous $64,000 164.06%

% of portfolio

0.05%

Previous 0.02%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 22, 2024	BUY	$101.21 - $166.61 $82,992 - $136,620	820 Added 136.44%	1,421 $169,000
Q4 2023 Jan 30, 2024	SELL	$69.51 - $104.43 $25,718 - $38,639	-370 Reduced 38.11%	601 $60,000
Q3 2023 Oct 11, 2023	BUY	$96.41 - $126.61 $35,671 - $46,845	370 Added 61.56%	971 $100,000
Q1 2023 Apr 11, 2023	SELL	$135.66 - $197.02 $99,031 - $143,824	-730 Reduced 54.85%	601 $92,000
Q4 2022 Jan 19, 2023	BUY	$118.38 - $210.04 $86,417 - $153,329	730 Added 121.46%	1,331 $239,000
Q3 2021 Oct 14, 2021	SELL	$221.9 - $484.47 $44,380 - $96,894	-200 Reduced 24.97%	601 $231,000
Q1 2021 Apr 14, 2021	BUY	$109.18 - $185.98 $87,453 - $148,969	801 New	801 $105,000
Q2 2020 Jul 27, 2020	SELL	$29.67 - $80.0 $248,634 - $670,400	-8,380 Closed	0 $0
Q1 2020 May 06, 2020	BUY	$17.78 - $31.58 $88,900 - $157,900	5,000 Added 147.93%	8,380 $251,000
Q4 2019 Jan 10, 2020	BUY	$13.93 - $21.28 $1,950 - $2,979	140 Added 4.32%	3,380 $66,000
Q3 2019 Oct 11, 2019	SELL	$12.26 - $18.07 $61,054 - $89,988	-4,980 Reduced 60.58%	3,240 $52,000
Q2 2019 Jul 15, 2019	BUY	$13.7 - $28.34 $49,457 - $102,307	3,610 Added 78.31%	8,220 $120,000
Q1 2019 Apr 10, 2019	BUY	$14.45 - $23.7 $31,284 - $51,310	2,165 Added 88.55%	4,610 $93,000
Q4 2018 Feb 07, 2019	BUY	$13.52 - $18.8 $33,056 - $45,966	2,445 New	2,445 $37,000

Others Institutions Holding MRNA

# of Institutions

1,045

Shares Held

242M

Call Options Held

9.26M

Put Options Held

12.1M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $21.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Canton Hathaway, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Canton Hathaway, LLC with notifications on news.

Account

Canton Hathaway, LLC Moderna, Inc. Transaction History